Pfizer Inc. (NYSE:PFE) [Trend Analysis] moved up reacts as active mover, shares an increase 0.57% to traded at $33.38 and the percentage gap between open changing to regular change was -0.78%. Anacor Pharma to be acquire by Pfizer (PFE) for $99.25 per share for a total transaction value, net of cash, of $5.2 billion (ANAC). Pfizer states, “Anacor will be a strong fit with Pfizer’s innovative business, further supporting our strategic focus on Inflammation and Immunology, and is expected to enhance near-term revenue growth for the innovative business.” The Boards of Directors of both companies have unanimously approved the transaction.
Pfizer anticipates financing the transaction through existing cash. Pfizer does not expect the transaction to impact its current 2016 financial guidance. Pfizer expects the transaction to be slightly dilutive to Adj. Diluted EPS in 2017 with accretion to Adj. Diluted EPS beginning in 2018 and increasing thereafter. The closing of the tender offer is subject to customary closing conditions, including U.S. antitrust clearance and the tender of a majority of the outstanding shares of Anacor common stock. The firm’s current ratio calculated as 1.40 for the most recent quarter. The firm past twelve months price to sales ratio was 4.05 and price to cash ratio remained 10.63. The firm has total debt to equity ratio measured as 0.62.
Kimberly-Clark Corporation (NYSE:KMB) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it 0.30% to close at $129.58 with the total traded volume of 922755 shares. Kimberly-Clark Corporation (KMB) declared that Suja Chandrasekaran has been named chief information officer, reporting to Maria Henry, senior vice president and chief financial officer. Ms. Chandrasekaran brings more than 25 years of experience in technology and leadership roles in both the consumer packaged goods and retail industries. “Suja has a strong track record of leading technology and digital organizations to deliver significant value to customers and across an enterprise,” said Henry. “I look forward to leveraging her expertise in developing innovative technology solutions to deliver strong value to K-C.” The firm has institutional ownership of 70.30%, while insider ownership included 0.10%. Its price to sales ratio ended at 2.56. KMB attains analyst recommendation of 2.70 with week performance of 1.13%.